MHRA Offers Roadmap for Reporting Drug Defects

Drug Industry Daily
A A
The UK’s Medicines and Healthcare products Regulatory Agency (MRHA) is reminding drugmakers they must report all defects in medicinal products that could lead to a recall immediately upon discovery and provide regular updates on internal investigations into the defects.

To View This Article:

Login

Subscribe To Drug Industry Daily